Page last updated: 2024-11-04

sulfinpyrazone and Glomerulonephritis

sulfinpyrazone has been researched along with Glomerulonephritis in 5 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis."6.15Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
George, CR1
Clark, WF1
Cameron, JS1
Thiele, KG1
Harker, LA2
Arieff, AI1
Pinggera, WF1

Reviews

3 reviews available for sulfinpyrazone and Glomerulonephritis

ArticleYear
The role of platelets in glomerulonephritis.
    Advances in nephrology from the Necker Hospital, 1975, Volume: 5

    Topics: Adenosine; Antidepressive Agents; Aspirin; Blood Platelets; Complement System Proteins; Endothelium;

1975
Antiplatelet drugs in the management of patients with thrombotic disorders.
    Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:2

    Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets

1986
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Circulation, 1986, Volume: 73, Issue:2

    Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical

1986

Trials

1 trial available for sulfinpyrazone and Glomerulonephritis

ArticleYear
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Circulation, 1986, Volume: 73, Issue:2

    Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical

1986

Other Studies

2 other studies available for sulfinpyrazone and Glomerulonephritis

ArticleYear
[Special pharmacotherapy of primary glomerulonephritis in the adult].
    Deutsche medizinische Wochenschrift (1946), 1975, Sep-05, Volume: 100, Issue:36

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anticoagulants; Azathioprine; Cyclophosphamide; Dipyrid

1975
Rapidly progressive glomerulonephritis treated with anticoagulants.
    Archives of internal medicine, 1972, Volume: 129, Issue:1

    Topics: Adult; Aged; Anticoagulants; Azathioprine; Blood Urea Nitrogen; Creatinine; Dipyridamole; Diuresis;

1972